# Efficacy Study of Botox to Treat Neuropathic Pain

> **NCT00527202** · PHASE4 · COMPLETED · sponsor: **Hospital Ambroise Paré Paris** · enrollment: 29 (actual)

## Conditions studied

- Postherpetic Neuralgia
- Nerve Trauma

## Interventions

- **DRUG:** botulinum toxin A

## Key facts

- **NCT ID:** NCT00527202
- **Lead sponsor:** Hospital Ambroise Paré Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2021-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00527202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00527202, "Efficacy Study of Botox to Treat Neuropathic Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00527202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*